Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学NSCLC Osimertinib Adjuvant

Roy Herbst

MD, PhD

🏢Yale Cancer Center🌐USA

Chief of Medical Oncology, Smilow Cancer Hospital

145
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Roy Herbst is a towering figure in lung cancer research who has led pivotal trials of EGFR-targeted therapy and immunotherapy. He has been a key investigator in osimertinib adjuvant studies and ADAURA trial follow-up analyses. His translational work on biomarkers and resistance mechanisms continues to drive innovation in thoracic oncology.

Share:

🧪Research Fields 研究领域

Lung cancer
EGFR-targeted therapy
Osimertinib adjuvant
Immunotherapy
Translational research

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Roy Herbst 的研究动态

Follow Roy Herbst's research updates

留下邮箱,当我们发布与 Roy Herbst(Yale Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment